You have no items in your shopping cart.
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 66.5 KDa. Observed: 71 KDa, reducing conditions
Human
Thr25-Asp381
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 36.7 KDa. Observed: 50-65 KDa, reducing conditions
Cynomolgus
Phe22-Ala105
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.7 KDa. Observed: 30 KDa, reducing conditions
Human
Met1-Pro229
N-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 45.85 KDa. Observed: 60 KDa, reducing conditions
Human
Met1-Leu441
Tag free
1 mg, 500 μg, 10 μg, 50 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 33.9 KDa. Observed: 37 KDa, reducing conditions
Human
Met1-Ser318
Tag free
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 67.5 KDa. Observed: 93 KDa, reducing conditions
Human
Gly39-His393
C-Fc
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 11.6 KDa. Observed: 18 KDa, reducing conditions
Human
Met1-Phe103
Tag free
10 μg, 50 μg, 1 mg, 500 μgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 37 KDa. Observed: 38-42 KDa, reducing conditions
Human
Ala26-Phe118
C-Fc
10 μg, 1 mg, 50 μg, 500 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 30.8 KDa. Observed: 50-60 KDa, reducing conditions
Cynomolgus
Ser18-Gly287
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 20.6 KDa. Observed: 16-20 KDa, reducing conditions
Human
Arg71-Glu254
C-6His
10 μg, 50 μg, 500 μg, 1 mg
